May endocan be a new biomarker in the diagnosis of endometriosis?

Cimilli Şenocak, Gamze; Yapça, Ömer; Topdağı Yılmaz, Emsal; Öztürk, Nurinnisa; Ozdes, Sevda; Kumtepe, Yakup

doi:10.1016/j.jogoh.2022.102423

May endocan be a new biomarker in the diagnosis of endometriosis?

Cimilli Şenocak G. N., Yapça Ö. E., Topdağı Yılmaz E. P., Öztürk N., Ozdes S., Kumtepe Y.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, cilt.51, sa.7, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 7
Basım Tarihi: 2022
Doi Numarası: 10.1016/j.jogoh.2022.102423
Dergi Adı: JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Endocan, Endometriosis, Biomarker, PATHOPHYSIOLOGY, PATHOGENESIS, SERUM, PAIN
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Atatürk Üniversitesi Adresli: Evet

Özet

Aim: As known, inflammatory substances are considered to have a role in the onset and progression of endometriosis. In this study, we aimed to find a biomarker that can be used in the diagnosis of endometriosis by investigating the serum levels of endocan, which is a substance that we know to have an important role in angiogenesis and inflammation, in patients with endometriosis.